Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients in Premenopausal”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04997941
What this trial is testing

Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients

Who this might be right for
Premenopausal Breast CancerHormone Receptor-positive Breast Cancer
Seoul National University Hospital 238
Large-scale testing (Phase 3)WithdrawnNCT00888082
What this trial is testing

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

Who this might be right for
Breast CancerOvarian Function
AstraZeneca 102
Large-scale testing (Phase 3)Study completedNCT00605267
What this trial is testing

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Who this might be right for
Breast Cancer
AstraZeneca 197
Large-scale testing (Phase 3)UnknownNCT03664895
What this trial is testing

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 224
Testing effectiveness (Phase 2)Looking for participantsNCT07460752
What this trial is testing

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
Mayo Clinic 98
Not applicableStudy completedNCT07127315
What this trial is testing

Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Who this might be right for
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausal+2 more
Helwan University 100
Large-scale testing (Phase 3)UnknownNCT01622361
What this trial is testing

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 290
Early research (Phase 1)Study completedNCT02058381
What this trial is testing

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Pre-menopausal Breast CancerPI3K Pathway Inhibition
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT00498901
What this trial is testing

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
University of Washington 1
Large-scale testing (Phase 3)Looking for participantsNCT07106632
What this trial is testing

Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests

Who this might be right for
Early Breast CancerPremenopausal Breast CancerHR+/HER2- Breast Cancer
UNICANCER 3,380
Testing effectiveness (Phase 2)Ended earlyNCT01864798
What this trial is testing

Evaluate Denosumab in Young Patients With Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Jules Bordet Institute 27
Not applicableUnknownNCT06313476
What this trial is testing

AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 153
Testing effectiveness (Phase 2)Study completedNCT03397537
What this trial is testing

Neoadjuvant Endocrine Therapy in Breast Cancer

Who this might be right for
Highly Endocrine Responsive Operable Breast Cancer
Guangdong Provincial People's Hospital 46
Not applicableStudy completedNCT02134977
What this trial is testing

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

Who this might be right for
Breast Cancer
Takeda 2,816
Post-approval studies (Phase 4)Study completedNCT02344940
What this trial is testing

Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 104
Large-scale testing (Phase 3)Looking for participantsNCT05827081
What this trial is testing

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Who this might be right for
Early Breast Cancer
Novartis Pharmaceuticals 1,400
Testing effectiveness (Phase 2)Study completedNCT03481998
What this trial is testing

SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 104
Large-scale testing (Phase 3)Study completedNCT06009627
What this trial is testing

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 119
Testing effectiveness (Phase 2)Ended earlyNCT01776008
What this trial is testing

Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeRecurrent Breast Carcinoma+5 more
National Cancer Institute (NCI) 16
Not applicableUnknownNCT03543059
What this trial is testing

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Sun Yat-sen University 2,000
Next Page